DK4000628T3 - Composition and method for vancomycin oral liquid - Google Patents
Composition and method for vancomycin oral liquidInfo
- Publication number
- DK4000628T3 DK4000628T3 DK21206424.0T DK21206424T DK4000628T3 DK 4000628 T3 DK4000628 T3 DK 4000628T3 DK 21206424 T DK21206424 T DK 21206424T DK 4000628 T3 DK4000628 T3 DK 4000628T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- oral liquid
- vancomycin oral
- vancomycin
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953076P | 2014-03-14 | 2014-03-14 | |
| US201461992414P | 2014-05-13 | 2014-05-13 | |
| EP15761279.7A EP3145527B1 (en) | 2014-03-14 | 2015-03-13 | Composition and method for vancomycin oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4000628T3 true DK4000628T3 (en) | 2026-01-12 |
Family
ID=54072499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21206424.0T DK4000628T3 (en) | 2014-03-14 | 2015-03-13 | Composition and method for vancomycin oral liquid |
Country Status (9)
| Country | Link |
|---|---|
| US (11) | US10959946B2 (da) |
| EP (2) | EP4000628B1 (da) |
| JP (1) | JP6552528B2 (da) |
| CN (1) | CN106573037A (da) |
| AU (1) | AU2015229069A1 (da) |
| DK (1) | DK4000628T3 (da) |
| ES (2) | ES2903419T3 (da) |
| FI (1) | FI4000628T3 (da) |
| WO (1) | WO2015138983A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6552528B2 (ja) | 2014-03-14 | 2019-07-31 | キューティスファーマ インコーポレーテッドCutispharma, Inc. | バンコマイシン経口液体のための組成物および方法 |
| RS59851B1 (sr) * | 2014-11-06 | 2020-02-28 | Xellia Pharmaceuticals Aps | Kompozicije glikopeptida |
| EP3402463B1 (en) | 2016-01-15 | 2021-04-14 | SciDose Pharma LLC | Formulations of vancomycin |
| EP4051285A4 (en) * | 2019-10-28 | 2023-12-06 | Brillian Pharma Inc. | Pharmaceutical unit dose systems for oral dry solution and suspension |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518581A (en) | 1981-11-02 | 1985-05-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Imparting low- or anti-cariogenic property to orally-usable products |
| US4670258A (en) | 1984-02-10 | 1987-06-02 | Vanderbilt University | Storable prepackaged aqueous solutions of vancomycin |
| US5362758A (en) | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| WO1997019690A1 (en) | 1995-12-01 | 1997-06-05 | Eli Lilly And Company | Stable vancomycin hydrochloride solutions |
| US20040191276A1 (en) * | 1999-11-30 | 2004-09-30 | Cutispharma, Inc. | Compositions and kits for compounding pharmaceuticals |
| AU2231601A (en) | 1999-12-28 | 2001-07-09 | Meiji Seika Kaisha Ltd. | Vancomycin preparations |
| WO2003020200A2 (en) | 2000-11-16 | 2003-03-13 | New River Pharmaceuticals Inc. | A novel pharmaceutical compound and methods of making and using same |
| ES2373641T3 (es) | 2000-11-16 | 2012-02-07 | Shire Llc | Un nuevo compuesto farmacéutico y métodos para fabricarlo y usarlo. |
| BR0207930A (pt) | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
| JP2002319184A (ja) * | 2001-04-20 | 2002-10-31 | Tdk Corp | 光記録媒体 |
| JP2003235497A (ja) | 2002-02-19 | 2003-08-26 | Sanei Gen Ffi Inc | 液状甘味料組成物 |
| US8021682B2 (en) * | 2004-08-13 | 2011-09-20 | Gallipot, Inc. | Palatable suspending vehicle for pharmaceutical ingredients |
| CN1857716A (zh) * | 2006-03-14 | 2006-11-08 | 浙江大学 | 注射用盐酸万古霉素及其制备方法 |
| CA2651988A1 (en) * | 2006-05-12 | 2007-11-22 | Adventrx Pharmaceuticals, Inc. | Pharmaceutical compositions for vein irritating drugs |
| JP2008201778A (ja) * | 2007-01-25 | 2008-09-04 | Mochida Pharmaceut Co Ltd | バンコマイシン液状製剤 |
| EP2055309A1 (en) * | 2007-10-31 | 2009-05-06 | Pharmatex Italia Srl | Vancomycin and Teicoplanin anhydrous formulations for topical use |
| US8551762B2 (en) * | 2009-07-07 | 2013-10-08 | Nch Corporation | System and apparatus for feeding, solubilizing, growing and discharging a biological material |
| TR200906775A1 (tr) * | 2009-09-02 | 2011-03-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Nimesulid ve kas gevşetici kombinasyonları |
| TW201109587A (en) * | 2009-09-10 | 2011-03-16 | I Chiun Precision Ind Co Ltd | LED illuminate device capability of increasing illumination |
| CA2823628A1 (en) * | 2011-01-05 | 2012-07-12 | Hospira, Inc. | Spray drying vancomycin |
| US9572774B2 (en) * | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
| CA2836643C (en) * | 2011-05-19 | 2017-11-14 | Savara, Inc. | Dry powder vancomycin compositions and associated methods |
| EP2805959A1 (en) * | 2012-03-15 | 2014-11-26 | Dow Corning Corporation | Alternative methods for the synthesis of organosilicon compounds |
| KR20140009819A (ko) * | 2012-07-13 | 2014-01-23 | 주식회사유한양행 | 반코마이신 또는 그의 염 및 덱사메타손 포스페이트 또는 그의 염을 포함하는 국소투여용 약학 조성물 |
| WO2014194296A1 (en) | 2013-05-30 | 2014-12-04 | Scidose, Llc | Formulations of vancomycin |
| EP3160592B1 (en) * | 2014-02-27 | 2018-10-31 | The Procter and Gamble Company | Compositions with reduced bitter taste perception |
| JP6552528B2 (ja) | 2014-03-14 | 2019-07-31 | キューティスファーマ インコーポレーテッドCutispharma, Inc. | バンコマイシン経口液体のための組成物および方法 |
| PL408834A1 (pl) * | 2014-07-11 | 2016-01-18 | Uniwersytet Warszawski | Konsorcjum i preparat mikroorganizmów do katalizowania hydrolizy celulozy, preparat do suplementacji fermentacji metanowej, preparat złożony oraz zastosowanie i sposób je wykorzystujące |
-
2015
- 2015-03-13 JP JP2016575639A patent/JP6552528B2/ja active Active
- 2015-03-13 FI FIEP21206424.0T patent/FI4000628T3/fi active
- 2015-03-13 EP EP21206424.0A patent/EP4000628B1/en active Active
- 2015-03-13 DK DK21206424.0T patent/DK4000628T3/da active
- 2015-03-13 AU AU2015229069A patent/AU2015229069A1/en not_active Abandoned
- 2015-03-13 EP EP15761279.7A patent/EP3145527B1/en active Active
- 2015-03-13 ES ES15761279T patent/ES2903419T3/es active Active
- 2015-03-13 CN CN201580024739.9A patent/CN106573037A/zh active Pending
- 2015-03-13 US US15/126,059 patent/US10959946B2/en active Active
- 2015-03-13 ES ES21206424T patent/ES3057232T3/es active Active
- 2015-03-13 WO PCT/US2015/020575 patent/WO2015138983A1/en not_active Ceased
-
2017
- 2017-10-24 US US15/791,717 patent/US10493028B2/en active Active
-
2019
- 2019-11-06 US US16/676,325 patent/US10688046B2/en active Active
-
2020
- 2020-06-04 US US16/892,421 patent/US10959947B2/en active Active
- 2020-07-28 US US16/941,414 patent/US10959949B2/en active Active
- 2020-07-28 US US16/941,400 patent/US10959948B2/en active Active
- 2020-08-07 US US16/988,387 patent/US20210023002A1/en not_active Abandoned
- 2020-10-22 US US17/077,969 patent/US20210038515A1/en not_active Abandoned
-
2021
- 2021-02-02 US US17/165,754 patent/US20210169799A1/en not_active Abandoned
-
2022
- 2022-09-28 US US17/954,703 patent/US20230301907A1/en not_active Abandoned
- 2022-10-13 US US17/965,253 patent/US11638692B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200360283A1 (en) | 2020-11-19 |
| US10959949B2 (en) | 2021-03-30 |
| US20200352858A1 (en) | 2020-11-12 |
| US10688046B2 (en) | 2020-06-23 |
| US10959948B2 (en) | 2021-03-30 |
| EP4000628A1 (en) | 2022-05-25 |
| WO2015138983A1 (en) | 2015-09-17 |
| FI4000628T3 (fi) | 2025-12-18 |
| US20210038515A1 (en) | 2021-02-11 |
| CA2941867A1 (en) | 2015-09-17 |
| CN106573037A (zh) | 2017-04-19 |
| US20200306186A1 (en) | 2020-10-01 |
| US20180116955A1 (en) | 2018-05-03 |
| EP3145527B1 (en) | 2021-12-01 |
| ES2903419T3 (es) | 2022-04-01 |
| EP4000628B1 (en) | 2025-09-24 |
| US20200069584A1 (en) | 2020-03-05 |
| US20230102830A1 (en) | 2023-03-30 |
| US20230301907A1 (en) | 2023-09-28 |
| EP3145527A4 (en) | 2018-01-03 |
| JP6552528B2 (ja) | 2019-07-31 |
| JP2017508807A (ja) | 2017-03-30 |
| AU2015229069A1 (en) | 2016-11-03 |
| US20210023002A1 (en) | 2021-01-28 |
| US10493028B2 (en) | 2019-12-03 |
| EP3145527A1 (en) | 2017-03-29 |
| US10959946B2 (en) | 2021-03-30 |
| US11638692B2 (en) | 2023-05-02 |
| US10959947B2 (en) | 2021-03-30 |
| US20210169799A1 (en) | 2021-06-10 |
| ES3057232T3 (en) | 2026-02-27 |
| US20170079910A1 (en) | 2017-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286025A (en) | Nanoparticle preparations and immunotherapy methods | |
| IL251995A0 (en) | A device and method for characterizing a substance | |
| GB2545588B (en) | System and method for image composition | |
| SG11201701115YA (en) | Method and apparatus for managing background application | |
| SG10202109655VA (en) | Compositions and methods for immunooncology | |
| EP3216562A4 (en) | Polishing method and composition for polishing | |
| SG10202004858TA (en) | Composition and method for aiding sleep | |
| EP3093875A4 (en) | Liquid composition for semiconductor element cleaning and method for cleaning semiconductor element | |
| IL250119A0 (en) | Purification device and method | |
| IL246879A0 (en) | Preparations of Epilimod and methods of using them | |
| SG11201608128UA (en) | Polishing composition and polishing method | |
| GB201410325D0 (en) | Method and apparatus for disinfection | |
| ZA201607571B (en) | Compositions and methods for detecting huanglongbing | |
| GB201520255D0 (en) | Composition and method | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
| DK4000628T3 (en) | Composition and method for vancomycin oral liquid | |
| ZA201700303B (en) | Oral composition and methods for immunotherapy | |
| IL250193A0 (en) | A cheese compound and a process for its preparation | |
| GB201513866D0 (en) | Method and apparatus for electrocagulation | |
| GB201509420D0 (en) | Composition and method | |
| GB201415250D0 (en) | Compound and method | |
| GB201401253D0 (en) | Improved sealing apparatus and method | |
| PT3160263T (pt) | Composições para prevenção de infeções | |
| GB2532019B (en) | Packing method and apparatus |